Cynthia Bosquillon

Dr. Cynthia Bosquillon

School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, United Kingdom
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2010 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
Cynthia BosquillonCynthia Bosquillon
Cynthia Bosquillon

21 May 2012 in Soft Matter
Verified
Journal Article
Closed access
PDF file
SNSelina Nawaz
Selina Nawaz
MRMartin Redhead
Martin Redhead
Giuseppe MantovaniGiuseppe Mantovani
Giuseppe Mantovani
CACameron Alexander
Cameron Alexander
Cynthia BosquillonCynthia Bosquillon
Cynthia Bosquillon
PCPaola Carbone
Paola Carbone
Poly(ethylene oxide) (PEO) and poly(propylene oxide) (PPO) block co-polymers (PEO–PPO–PEO, sold as Pluronics, Poloxamers, Tetronics) are a widely used class of amphiphilic materials for different biological applications. In fact for certain members of the Pluronics series, the interactions of block segments with living cells alter the lipid membrane properties and facilitate the permeation of drugs. A fuller understanding of the molecular mechanisms underpinning these interactions is essential for ensuring their safety and efficacy in biomedical applications and to inform the design of new amphiphilic copolymers for potential use in a clinical setting. In this paper, by means of atomistic molecular dynamics simulations and membrane lysis assays, we investigate the relationship between the molecular conformations of a subset of the Pluronic copolymers (L31, L61, L62 and L64) and their haemolytic activity. Our computational studies suggest that the hydrophilic blocks in these copolymers interact with the polar head groups of lipid molecules, resulting in a predicted modification of the structure of the membranes. Parallel membrane lysis assays in human erythrocytes indicate differences in the rates of haemolysis, as a result of incubation with these polymers, that correlate well with the predicted interactions from the atomistic simulations. The computational data thus provide a putative mechanism to rationalize the available experimental data on membrane lysis by these copolymers and quantitatively agree with haemoglobin release endpoints measured when copolymers with the same molecular weight and structure as of those modelled are incubated with erythrocytes. The data further suggest some new structure–function relationships at the nanoscale that are likely to be of importance in determining the biological activity of these otherwise inert copolymers.

1 August 2019 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Open access
ECEmanuela Cingolani
Emanuela Cingolani
SASafar Alqahtani
Safar Alqahtani
RSRobyn C Sadler
Robyn C Sadler
DPDavid Prime
David Prime
SSSnow Stolnik
Snow Stolnik
Cynthia BosquillonCynthia Bosquillon
Cynthia Bosquillon
Although the mucus layer is the first biological barrier encountered by inhaled drugs upon their deposition in the upper airways, its potential impact on drug dissolution and absorption in the lung has hardly been investigated. Bio-relevant in vitro models were therefore used to assess the role of airway mucus in the fate of drug particles at the air-epithelium interface. Salbutamol and indomethacin were used as model Biopharmaceutics Classification System (BCS) class III and class II drugs, respectively. Dry powders were reproducibly aerosolised using a PennCentury™ Dry Powder Insufflator onto multiple air-liquid interfaced layers of the broncho-epithelial cell line Calu-3 or thin layers of porcine tracheal mucus mounted onto Transwells® inserts, as well as on empty Transwells®. Comparison of the permeation profiles of the two drugs indicated that mucus acted as a barrier for salbutamol transport but increased that of indomethacin, suggesting it facilitates the dissolution of poorly soluble drugs. In presence of Calu-3 layers, the permeability of salbutamol was even more restricted while indomethacin transport was enhanced further. This study demonstrates mucus distinctly affects the absorption characteristics of drugs with different physico-chemical properties. Hence, drug-mucus interactions should be considered during the development of inhaled drugs.

1 April 2012 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MMManali Mukherjee
Manali Mukherjee
DPD.I. Pritchard
D.I. Pritchard
Cynthia BosquillonCynthia Bosquillon
Cynthia Bosquillon

3 March 2012 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
MRMartin Redhead
Martin Redhead
Giuseppe MantovaniGiuseppe Mantovani
Giuseppe Mantovani
SNSelina Nawaz
Selina Nawaz
PCPaola Carbone
Paola Carbone
Dariusz C GoreckiDariusz C Gorecki
Dariusz C Gorecki
Cynthia BosquillonCynthia Bosquillon
Cynthia Bosquillon

1 August 2017 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
MMManali Mukherjee
Manali Mukherjee
ECE. Cingolani
E. Cingolani
DPD.I. Pritchard
D.I. Pritchard
Cynthia BosquillonCynthia Bosquillon
Cynthia Bosquillon